期刊文献+

恒河猴P21基因在COS-7细胞中沉默位点的验证

Validation of the silencing site of rhesus monkey P21 gene in COS-7 cells
下载PDF
导出
摘要 目的在细胞水平筛选恒河猴P21基因的有效沉默靶点。方法检测COS-7中P21基因的表达水平;设计shRNA并构建P21-RNA干扰慢病毒载体FUGW-TDT-P21shRNA转染COS-7细胞,通过real-time PCR检测沉默效率,并以Western blot在蛋白水平进行验证。结果筛选到四个有效的靶位,分别位于P21 mRNA的541-561、542-562、215-239、624-648 bp。四个靶位点在mRNA水平的沉默效率分别为(91.82±3.21)%、(82.47±2.48)%、(81.31±2.69)%和(87.35±4.59)%。相应的蛋白表达量为(11.97±0.70)%、(20.22±0.65)%、(23.21±0.63)%和(14.42±0.86)%。结论在细胞水平筛选得到四个有效的P21基因沉默靶点,可用于恒河猴基因沉默研究。 Objective To screen the effective silencing targets of P21 gene at the cellular level in rhesus monkey.Methods To detect the expression of P21 gene in COS-7 cells( derived from the kidney of African green monkey,Cercopithecus aethiops). Four small hairpin RNA( shRNA) sequences targeting rhesus monkey P21 gene were designed and inserted into lentivirus-based gene silencing constructs FUGW-TDT. The vectors were transfected into COS-7 cells respectively. The suppression of P21 mRNA was detected by real-time PCR,and the expression of P21 protein was detected by Western blot assay. Results Four gene-silencing sequences were screened that lied in 541-561 bp,542-562 bp,215-239 bp,and 624-648 bp of the rhesus monkey P21 mRNA. Their silencing rate was( 91. 82 ±3. 21) %,( 82. 47 ±2. 48) %,( 81. 31±2. 69) % and( 87. 35 ±4. 59) %,and the protein expression was( 11. 97 ±0. 70) %,( 20. 22 ±0. 65) %,( 23. 21 ±0. 63) % and( 14. 42 ±0. 86) %,respectively. Conclusions Four effective silencing target sequences are screened at cellular level,which can be used in gene silencing research of rhesus monkeys.
出处 《中国实验动物学报》 CAS CSCD 北大核心 2015年第3期297-300,共4页 Acta Laboratorium Animalis Scientia Sinica
基金 国家科技支撑计划(No.2014BAI03B01)
关键词 基因沉默 P21基因 恒河猴 Gene silencing P21 gene Rhesus monkey
  • 相关文献

参考文献9

  • 1De la Cueva E,García-Cao I,Herranz M,López P,García-Palencia P,Flores J M,Serrano M,Fernández-Piqueras J,Martín-Caballero J.Tumorigenic activity of p21Waf1/Cip1 in thymic lymphoma. Oncegene . 2006
  • 2Eric JV,Gregory MM.Nonhuman primate models in the genomic era:a paradigm shift. ILAR Journal . 2013
  • 3David A. Eastmond,Suryanarayana V. Vulimiri,John E. French,Babasaheb Sonawane.The use of genetically modified mice in cancer risk assessment: Challenges and limitations*[J]. Critical Reviews in Toxicology . 2013 (8)
  • 4Rachel E.Cianciolo,Stephanie D.Butler,Jeffery S.Eggers,Edward J.Dick,M. MichelleLeland,MelissaDe La Garza,Kathleen M.Brasky,Larry B.Cummins,Gene B.Hubbard.Spontaneous neoplasia in the baboon (Papio spp.)[J]. Journal of Medical Primatology . 2007 (2)
  • 5Y. Alan Wang,Ari Elson,Philip Leder.Loss of p21 increases sensitivity to ionizing radiation and delays the onset of lymphoma in atm-deficient?mice. Proceedings of the National Academy of Sciences of the United States of America . 1997
  • 6H. W. Zhou,S. Q. Lou,K. Zhang.Recovery of function in osteoarthritic chondrocytes induced by p16INK4a-specific siRNA in vitro. Rheumatology . 2004
  • 7KE McKenzie,A Siva,S Maier,IB Runnebaum,R Seshadri,S Sukum.Altered WAF1 genes do not play a role in abnormal cell cycle regulation in breast cancers lacking p53 mutations. Clinical Cancer Research . 1997
  • 8Igor B Roninson.Oncogenic functions of tumour suppressor p21 Waf1/Cip1/Sdi1 : association with cell senescence and tumour-promoting activities of stromal fibroblasts[J]. Cancer Letters . 2002 (1)
  • 9苏静芬,张晨,李雨函,刘先菊,佟巍,向志光,石亮,石桂英,刘云波.恒河猴 p53基因沉默靶点在细胞水平的验证[J].中国比较医学杂志,2014,24(8):7-10. 被引量:3

二级参考文献8

  • 1Daniels TR, Mart:nez-Maza O, Penichet ML. Animal models for IgE-mediated cancer immunotherapy [ J ]. Cancer Immunol Immunother. 2012,61 (9) :1535 - 1546.
  • 2Beniashvili DS. An overview of the world literature on spontaneous tumors in nonhuman primates [ J ]. J Med Primatol, 1989,18:423 -437.
  • 3Cianciolo RE, Butler SD, Eggers JS, et al. Spontaneous neoplasia in the baboon [ J ]. J Med Primatol. 2007,36 (2) :61 - 79.
  • 4Anthony W, Chan S. Progress and prospects for genetic modification of nonhuman primate models in biomedical research [J]. ILAR J, 2013,54(2) :211 -223.
  • 5Soussi T,B6roud C. Assessing TP53 status in human turnouts to evaluate clinical outcome [ J ]. Nat Rev Cancer,2001,1 ( 3 ) :233 - 240.
  • 6Zhou HW, Lou SQ, Zhang K. Recovery of function in osteoarthritic chondrocytes induced by pi6INK4"'specifie siBNA in vitro[J]. Rheumatology,2004,43:555-568.
  • 7Olive KP,Tuvesen DA,Ruhe ZC,Yin B, et al. Mutant p53 gain of function in two mouse models of Li-Fraumeni syndrome [ J ]. Cell ,2004,119 ( 6 ) :847 - 860.
  • 8Lang GA,lwakuma T,Suh YA,et al. Gain of function of a p53 hot spot mutation in a mouse model of Li-Fraumeni syndrome [J]. Ce11,2004, 119(6) :861 -872.

共引文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部